logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries

Madec Y, Szumilin E, Genevier C, Ferradini LLF, Balkan S,  et al.
2009-04-27 • AIDS
2009-04-27 • AIDS
BACKGROUND
In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretrovira...
Journal Article
|
Research

Risk factors for buruli ulcer: a case control study in Cameroon

Pouillot R, Matias G, Wondje CM, Portaels F, Valin N,  et al.
2007-12-19 • PLOS Neglected Tropical Diseases
2007-12-19 • PLOS Neglected Tropical Diseases
BACKGROUND: Buruli ulcer is an infectious disease involving the skin, caused by Mycobacterium ulcerans. This disease is associated with areas where the water is slow-flowing or stagnant....
Journal Article
|
Research

Incidence, management, and outcome of childhood empyema: a prospective study of children in Cambodian refugee camps

Fontanet AL, McCauley RG, Coyette Y, Larchiver F, Bennish ML
1993-12-01 • American Journal of Tropical Medicine and Hygiene
1993-12-01 • American Journal of Tropical Medicine and Hygiene
To determine the incidence, outcome, and optimal management of empyema, all children less than 15 years of age admitted to Khao-I-Dang Hospital with a diagnosis of empyema during a 23-mo...
Journal Article
|
Research

Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)

Borand L, Madec Y, Laureillard D, Chou M, Marcy O,  et al.
2014-03-07 • PLOS One
2014-03-07 • PLOS One
OBJECTIVE
To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.
Journal Article
|
Research

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia

Madec Y, Laureillard D, Pinoges LLP, Fernandez MAL, Prak N,  et al.
2007-01-30 • AIDS
2007-01-30 • AIDS
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients. METHODS: Factors associated...